Cargando…
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Although targeted therapies are initially effective, resistance inevitably emerges. Several methods, such as genetic analysis of resistant clinical specimens, have been applied to uncover these resistance mechanisms to facilitate follow-up care. Although these approaches have led to clinically relev...
Autores principales: | Korpal, Manav, Feala, Jacob, Puyang, Xiaoling, Zou, Jian, Ramos, Alex H., Wu, Jeremy, Baumeister, Timm, Yu, Lihua, Warmuth, Markus, Zhu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692793/ https://www.ncbi.nlm.nih.gov/pubmed/26710000 http://dx.doi.org/10.3791/52879 |
Ejemplares similares
-
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
por: Teng, Teng, et al.
Publicado: (2017) -
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
por: Korpal, Manav, et al.
Publicado: (2017) -
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer
por: Korpal, Manav, et al.
Publicado: (2019) -
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer
por: Furman, Craig, et al.
Publicado: (2022) -
Uncover disease genes by maximizing information flow in the phenome–interactome network
por: Chen, Yong, et al.
Publicado: (2011)